 |
|
Differing attitudes found between women and doctors concerning menstrual suppression
October 04, 2007Two thirds of women interested in stopping their periods, but unsure about medical implications
PHILADELPHIA - More than the two thirds of the women in a national survey say that they are interested in suppressing their menstrual periods but many of them aren't sure if it's safe. Yet when physicians are polled, 97 percent say that continuous oral contraceptive therapy to suppress menstruation is, in fact, medically safe and acceptable. The survey results were presented by Kurt Barnhart MD, MSCE from the University of Pennsylvania School of Medicine at the Association of Reproductive Health Professionals' (ARHP) Reproductive Health 2007 conference.
"The gap between physician and patient understanding concerning the necessity of monthly periods is obvious," said Dr. Barnhart, Associate Professor and Director of Clinical Research for the Department of Obstetrics & Gynecology. "It is our hope that based on these findings physicians will begin to more readily initiate dialogue with their female patients about continuous therapy -- helping to eliminate the misconception that periods are a medical necessity and to emphasize the safety and viability of menstrual suppression."
Multiple oral contraceptives are already available to reduce menstruation and the FDA recently approved the first continuous oral contraceptive designed to suppress a woman's menstrual cycle. And according to this study, women are increasingly interested in exercising their options. The study found that 63 percent of women reported being extremely or somewhat interested in not having a period. Symptoms cited as the most bothersome aspects of menstruation included cramping, mood swings, bloating and headaches/body aches, while associated personal frustrations cited included avoiding exercise and sexual intercourse, eating more and a decrease in work productivity.
Why would a physician recommend a woman suppress her menses?
"The symptoms that often accompany menstruation - from depression to bloating and headaches - can significantly disrupt women's lives," said Dr. Barnhart. "Menstruation is not medically necessary. Now that we have products that have proven to be safe and effective at suppressing menstruation, we can offer increasing options for women."
Indeed it seems a clearer patient-physician dialogue is required to eliminate confusion regarding menstrual suppression and continuous use oral contraceptives. Of the 12% of patients who indicated that they have discussed the idea of eliminating or reducing periods with their doctor; nearly half of those said that they were the ones to raise the issue, not their physicians. But their physicians tell a different story. By contrast, four out of 5 physicians reported discussing continuous use oral contraceptive use with their patients, and 77% reported that they raised the topic.
This disconnect may be related to simple semantics, according to Dr. Barnhart.
"We've found that physicians and their patients discuss this topic differently, with doctors using the medical term menstrual suppression, while their patients simply talk about not having a period," he said. "Breaking down this language barrier by speaking in simpler, more patient-friendly terms could have a significant positive impact on understanding."
Oral contraceptives were initially designed with a week of inactive tablets taken every month to mimic the natural experience of menstruation. Continuous use oral contraceptives simply eliminate these inactive tablets, thereby eliminating withdrawal bleeding. A study published in the December, 2006 issue of Contraception demonstrated the safety and effectiveness of continuous-use oral contraceptives that can eliminate menstrual cycles. Researchers concluded that a continuous-use, low-dose regimen of oral contraceptives was safe and as effective as traditional oral contraceptives, and that the decrease in menstrual cycle symptoms during continuous use therapy represented an increase in quality of life.
University of Pennsylvania School of Medicine
Multiple oral contraceptives are already available to reduce menstruation and the FDA recently approved the first continuous oral contraceptive designed to suppress a woman's menstrual cycle. And according to this study, women are increasingly interested in exercising their options. The study found that 63 percent of women reported being extremely or somewhat interested in not having a period. Symptoms cited as the most bothersome aspects of menstruation included cramping, mood swings, bloating and headaches/body aches, while associated personal frustrations cited included avoiding exercise and sexual intercourse, eating more and a decrease in work productivity.
Why would a physician recommend a woman suppress her menses?
"The symptoms that often accompany menstruation - from depression to bloating and headaches - can significantly disrupt women's lives," said Dr. Barnhart. "Menstruation is not medically necessary. Now that we have products that have proven to be safe and effective at suppressing menstruation, we can offer increasing options for women."
Indeed it seems a clearer patient-physician dialogue is required to eliminate confusion regarding menstrual suppression and continuous use oral contraceptives. Of the 12% of patients who indicated that they have discussed the idea of eliminating or reducing periods with their doctor; nearly half of those said that they were the ones to raise the issue, not their physicians. But their physicians tell a different story. By contrast, four out of 5 physicians reported discussing continuous use oral contraceptive use with their patients, and 77% reported that they raised the topic.
This disconnect may be related to simple semantics, according to Dr. Barnhart.
"We've found that physicians and their patients discuss this topic differently, with doctors using the medical term menstrual suppression, while their patients simply talk about not having a period," he said. "Breaking down this language barrier by speaking in simpler, more patient-friendly terms could have a significant positive impact on understanding."
Oral contraceptives were initially designed with a week of inactive tablets taken every month to mimic the natural experience of menstruation. Continuous use oral contraceptives simply eliminate these inactive tablets, thereby eliminating withdrawal bleeding. A study published in the December, 2006 issue of Contraception demonstrated the safety and effectiveness of continuous-use oral contraceptives that can eliminate menstrual cycles. Researchers concluded that a continuous-use, low-dose regimen of oral contraceptives was safe and as effective as traditional oral contraceptives, and that the decrease in menstrual cycle symptoms during continuous use therapy represented an increase in quality of life.
University of Pennsylvania School of Medicine
Oral Contraceptive Current Events and Oral Contraceptive News RSSStudy explains potential failure of oral contraceptives with obese women
Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.
2 reproductive factors are important predictors of death from ovarian cancer
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.
Contraceptive use may be safe, but information gaps remain
Introduced in the 1960s, oral contraceptives have been used by about 80 percent of women in the United States at some point in their lives.
Birth control has long-term effect on hormone exposure
Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life.
Study identifies trends of vitamin B6 status in US population sample
In an epidemiological study, Tufts University researchers identified trends of vitamin B6 status in a sample of the United States population based on measures of plasma pyridoxal 5'- phosphate (PLP) levels in the bloodstream. Plasma PLP is the indicator used by the federal government to set the current Recommended Dietary Allowance (RDA) of vitamin B6, a nutrient essential for red blood cell function and important for maintaining a healthy immune system and blood glucose levels.
Hormone use related to lower risk of macular degeneration in postmenopausal women
Women who take postmenopausal hormones appear to have a lower risk of developing advanced stages of the eye disease age-related macular degeneration, especially if they had also taken oral contraceptives in the past, according to a report in the April issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
May inflammatory bowel disease mimic gynecological disorders in its clinical presentation
Endometriosis is a condition of unknown etiology in which endometrial tissue occurs at extra-uterine sites, including ovaries, fallopian tubes, and gastrointestinal tract.
Texas A&M testing oral contraceptives for animals
If you're a land owner and animals such as coyotes or wild pigs are driving you hog wild, help may soon be on the way to control their numbers in a humane way - in the form of a birth control pill for animals being developed at Texas A&M University's College of Veterinary Medicine & Biomedical Sciences.
HPV vaccine does not appear to be effective for treating pre-existing HPV infection
For women with human papillomavirus (HPV) infection, use of the HPV-16/18 vaccine will not accelerate reduction of the virus and should not be used to treat the infection, according to a study in the August 15 issue of JAMA.
Periodontal diseases are blind to age
Two new studies in the June issue of the Journal of Periodontology (JOP) suggest that periodontal diseases are a threat to women of all ages due to hormonal fluctuations that occur at various stages of their lives.
More Oral Contraceptive Current Events and Oral Contraceptive News Articles
|
Managing Contraceptive Pill Patients by Richard P. Dickey (Author) Louisiana State Univ., New Orleans. Contains most of the known oral contraceptive (OC) side effects and their causes with a recommended plan of management. Tables list categorical activities of OCs. Intended to help clinicians choose among OC types. Trim size: 7.5 x 4.25 inches. Softcover. | |
 |
On the Pill: A Social History of Oral Contraceptives, 1950-1970 by Elizabeth Siegel Watkins (Author) "In 1968, a popular writer ranked the pill's importance with the discovery of fire and the developments of tool-making, hunting, agriculture, urbanism, scientific medicine, and nuclear energy. Twenty-five years later, the leading British weekly, the Economist, listed the pill as one of the seven wonders of the modern world. The image of the oral contraceptive as revolutionary persists in popular culture, yet the nature of the changes it supposedly brought about has not been fully investigated. After more than thirty-five years on the market, the role of the pill is due for a thorough examination."—from the Introduction In this fresh look at the pill's cultural and medical history, Elizabeth Siegel Watkins re-examines the scientific and ideological forces that led to its... |
 |
OC Companion / 60 caps by Vitanica Oral contraceptives have been shown to lower the levels of six nutrients: riboflavin, B6, folic acid, vitamin B12, ascorbic acid and zinc. This formula was designed to provide selective nutritional support, promote enhanced hormonal metabolism and strengthen detoxification pathways.* Each vegetarian suitable capsule includes: Vitamin A (as Betatene®, natural mixed carotenoids), Vitamin C (as calcium ascorbate), Vitamin E (as d-alpha tocoperyl succinate), Vitamin B2 (as riboflavin), Vitamin B6 (as pyridoxal-5-phosphate), Folate (as folic acid), Vitamin B12 (as methylcobalamin), Zinc (as picolinate), Copper (as gluconate), DIM (Diindolymethane), Bromelain, L. acidolphilus, Dandelion root ~ Taraxacum officinale, Borage oil powder (8% GLA), Garlic (10,000 ppm allicin potential) |
 |
Summary of Drug Interactions with Oral Contraceptives (Summary of Oral Contraceptive Data Series) by T.B.P. Geurts (Author), E.M. Goorissen (Author) This volume is designed to help physicians in their daily practice by providing practical information in an accessible form. When prescribing drugs the physician has to take into consideration that concurrent administration may lead to drug interactions. This is especially so in the case of oral contraceptives, which are agents usually taken continuously for many years. Interactions due to the concurrent administration of an oral contraceptive and another drug may have two different implications - either reduced efficacy of the pill, or an altered pharmacological effect of the other drug (and, occasionally, as a result of the latter, even the occurence of adverse effects). Both types of interactions are reviewed. A systematic, classified approach is used throughout the text. Individual... |
 |
Sexual Chemistry: A History of the Contraceptive Pill by Dr. Lara V. Marks (Author) Heralded as the catalyst of the sexual revolution and the solution to global overpopulation, the contraceptive pill was one of the twentieth century's most important inventions. It has not only transformed the lives of millions of women but has also pushed the limits of drug monitoring and regulation across the world. This deeply- researched new history of the oral contraceptive shows how its development and use have raised crucial questions about the relationship between science, medicine, technology, and society. Lara Marks traces the scientific origins of the pill to Europe and Mexico in the early years of the twentieth century, challenging previous accounts that championed it as a North American product. She explores the reasons why the pill took so long to be ... |
 |
Summary of Contraindications to Oral Contraceptives by S. C. M. Knijff (Author), E. M. Goorissen (Author), E. J. M. Velthuis-Te Wierik (Author), T. Korver (Author), David A. Grimes (Author) This volume comprehensively summarizes all contraindications to oral contraceptives. It contains more than 90 individual chapters and topic-specific addenda in ten sections opening with general information on the safety of the pill, medical conditions, the literature and studies and epidemiological principles. The main sections of the book cover contraindications, the circulatory system, thromboembolic risk, the hemostasis system, risk factors for circulatory disease, the contraindication status of potentially relevant disorders, malignant conditions of the genital organs, severe diseases of the liver and biliary system, and a wide range of other conditions. Includes bibliographic references and index. |
 |
GLYDE Flavored Dental Dams: 3 units. by Global Protection Protect yourself and your partner during oral encounters with these flavored dental dams. Each 10" x 6" sheet comes in a variety of flavors, including VANILLA, WILDBERRY, STRAWBERRY, and COLA Don't forget the importance of oral safety with these FDA approved oral dams |
 |
Extragenital Effects of Oral Contraceptives by M. Elstein (Editor) This is a compact scientific monograph on the extragenital effects of a combined formulation of ethinylestradiol at an acceptable dose of 30 µg and the new progestogen, dienogest. The book contains five main chapters on cardiovascular risks, ideal doses, clinical experiences, and hormonal control of androgenic disorders in women. The studies reported in this volume are of special interest to practitioners and researchers because in clinical trials this new formulation has provided reliable contraceptive action with good cycle control and a high level of acceptability. These studies lend support to expectations derived from the basic pharmacological experimentations, mostly animal-based, showing that the new progestogen does not interfere with the metabolism of ethinylestradiol in the... |
|
OCs pose risk in women with migraine/aura.(News)(oral contraceptives): An article from: Internal Medicine News by Sharon Worcester (Author) This digital document is an article from Internal Medicine News, published by Thomson Gale on April 1, 2007. The length of the article is 594 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: OCs pose risk in women with migraine/aura.(News)(oral contraceptives) Author: Sharon Worcester Publication: Internal Medicine News (Magazine/Journal) Date: April 1, 2007 Publisher: Thomson Gale Volume: 40 Issue: 7 Page: 7(1) Distributed by Thomson... | |
 |
Submaximal Cycle Ergometry as a Predictor of Maximal Aerobic Capacity inWomen on Oral Contraceptives by Jannell C. MacAulay (Author) This is a AIR FORCE INST OF TECH WRIGHT-PATTERSONAFB OH report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A432073. The abstract provided by the Pentagon follows: Predicted maximal aerobic capacity (VO2max), using submaximal exercise tests, is used to evaluate fitness for job performance, especially within the military. Women who use oral contraceptives experience a rhythmic variation of circulating synthetic hormones that can influence submaximal exercising heart rate. The purpose of this study was to examine the validity and reliability of two submaximal heart... |
| © 2009 BrightSurf.com |